NVIDIA challenger CBRS soared 20%, rebounding above its issue price; buy-the-dip addresses in the below-issue-price zone once saw gains of up to 380%.

According to Hyperinsight monitoring, during U.S. stock trading hours, Nvidia challenger Cerebras (CBRS) rose as high as $242, with its gain expanding to 23%. Today's catalyst is Cerebras' strategic partnership with CrowdStrike, where the latter will use Cerebras' inference infrastructure to power the Falcon AI Detection and Response model, though the two sides did not disclose the contract amount. CBRS has thus re-stabilized above its IPO price of $185. On May 14, its first day of trading, the stock hit a high of $386.3 and closed at $311; after its first financial report, when the full-year core gross margin guidance fell short of expectations, the stock closed below its IPO price for the first time on June 25, and hit an all-time low of $160.81 on June 26. Calculated from today's high, CBRS has rebounded 49.2% from its all-time low, and is now 29.7% above its IPO price; however, it remains 37.9% below its all-time high of $386.34 on its first trading day, meaning it has only recouped its post-IPO decline and not yet returned to its first-day peak. A smart money address starting with 0xc262 first traded CBRS on July 18, opening a long position of 1036.35 shares via 217 trades during a brief second dip, at an average price of $173.6, for a total of approximately $179,000. Its cost is 6.1% lower than the IPO price. When CBRS rose to around $239.64 on Hyperliquid intraday, this 10x isolated long position once recorded a return of 380%. As of press time, the position is valued at about $237,700, with an unrealized profit of roughly $57,700, a return of 320.7%, and a liquidation price of $81.9.